Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Webinar: Tech-Enabled Trials from eSource to Centralized Monitoring and Modern Patient Experiences

August 18, 2022 at 3:30pm CT | Online

Join Vial CEO, Simon Burns, as he discusses Vial’s tech-enabled clinical trial Strategy. In this webinar we will cover clinical technologies such as eSource, centralized monitoring, and modern patient experiences.

Watch Now
webinar